FDA-cleared profile

SpineUs™ System

Verdure Imaging

Tracked B-mode ultrasound acquisition, display, and scoliosis-angle measurement of the spine for trained users as an adjunct to conventional imaging; it is not the sole basis for patient management.

Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.

Clinical details

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Tracked B-mode ultrasound acquisition, display, and scoliosis-angle measurement of the spine for trained users as an adjunct to conventional imaging; it is not the sole basis for patient management.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Trained chiropractors and radiologists qualified to perform and interpret musculoskeletal ultrasound.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Care setting and population
Hospitals and clinics performing superficial musculoskeletal ultrasound of the spine.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Adjunctive tracked-ultrasound acquisition, three-dimensional reconstruction, and scoliosis-angle measurement.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Required input
B-mode spinal ultrasound acquired with the tracked SpineUs transducer and compatible ultrasound components.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Output and human action
Three-dimensional reconstructed spinal images, AI-segmented bone surfaces, and user-reviewed scoliosis-angle measurements.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Use is adjunctive to conventional imaging and not the sole basis for patient management. The FDA study included 31 test subjects and showed larger mean absolute measurement differences in the greater-than-40-degree curvature subgroup.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K241029
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Spine
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-10-07
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The cleared system combines a tracked ultrasound transducer, workstation software, and B-mode input; the reviewed FDA summary does not establish PACS, RIS, or EHR interfaces.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Deployment and data flow
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-08

The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

Security and privacy
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-08

Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

Training and support
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-08

Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

Monitoring and change control
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-08

Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

Current product-family workflow context

Verdure describes the current SpineUs family as AI-enabled three-dimensional spinal ultrasound with AI segmentation and real-time reconstruction.

product family · checked 2026-09-08

Confirm exact-release availability, interfaces, hosting, security, support, and commercial terms during procurement.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA-described testing used a 31-subject test set independent from development data. Transverse processes were identified in all test cases; pixel-level bone segmentation sensitivity was 41.80% and specificity was 99.19%. Three observers compared ultrasound and radiograph scoliosis-angle measurements, with mean absolute differences increasing in the greater-than-40-degree curvature subgroup.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
41.80% pixel-level bone-segmentation sensitivity; this is not patient-level diagnostic sensitivity.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported specificity
99.19% pixel-level bone-segmentation specificity; this is not patient-level diagnostic specificity.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08

Transverse processes identified

100 percent

  • EndpointPercentage of transverse processes correctly identified in reconstructed three-dimensional ultrasound
  • PopulationIndependent nonclinical and clinical test dataset
  • Tested versionSpineUs configuration submitted in K241029

Pixel-level segmentation sensitivity

41.8 percent

  • EndpointBone-surface pixel segmentation sensitivity
  • PopulationIndependent ultrasound test dataset with expert pixel annotations
  • Tested versionSpineUs configuration submitted in K241029

Pixel-level segmentation specificity

99.19 percent

  • EndpointBone-surface pixel segmentation specificity
  • PopulationIndependent ultrasound test dataset with expert pixel annotations
  • Tested versionSpineUs configuration submitted in K241029

Mean absolute scoliosis-angle difference for curvature over 40 degrees

5.57 degrees

  • EndpointAbsolute difference between SpineUs and radiograph scoliosis-angle measurements
  • PopulationSubjects with radiographic spinal curvature greater than 40 degrees
  • Tested versionSpineUs configuration submitted in K241029

SpineUs segmentation and scoliosis-angle validation

  • DesignIndependent test-set evaluation of AI bone-surface segmentation and three-observer comparison of ultrasound and radiograph scoliosis-angle measurements.
  • Population31 subjects spanning less-than-20-degree, 20-to-40-degree, and greater-than-40-degree spinal-curvature subgroups.
  • Scopeexact submission
  • Tested versionSpineUs configuration submitted in K241029
  • Samplen=31
  • IndependenceSponsor or vendor study

K241029

FDA submission evidence; not an independent clinical-outcomes study.

Costs and setup

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-08

No public price or quote for the exact K241029 configuration was established in this review.

Reimbursement and coding
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-08

No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K241029. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-08Last searched
19Fields reviewed
9Source classes checked
0Awaiting review PubMed leads
0Awaiting review trial leads
0Unreviewed FDA recall leads

Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact FDA scope controls clinical claims. ACR and official vendor material provide bounded catalog or product-family context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, vendor product page, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Sources & history

How this profile was documented

Open the ledger for source dates, scope, and research-record updates.

View source ledger and history

Source ledger

  1. FDA K241029: SpineUs™ System

    U.S. Food and Drug Administration - Published 2024-10-07 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. openFDA exact recall query for K241029

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

  7. SpineUs AI-enabled 3D ultrasound

    Verdure Imaging - Accessed 2026-09-08

    Scope: productFamily, clinicalWorkflow, implementationCapabilities

Research history

  1. K241029 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

Alternatives

Related tools to compare

FDA-cleared K243937

Accuro 3S

Rivanna Medical, Inc.

Accuro 3S is portable B-mode ultrasound with SpineNav-AI for lumbar-spine scouting and epidural-depth estimation during neuraxial-anesthesia and needle or catheter placement...

Modality
Ultrasound
Anatomy
Spine
Decision
2025-05-23
FDA-cleared K252237

EdgeFlow UW20

Edgecare, Inc.

EdgeFlow UW20 is a wearable ultrasound system for noninvasive periodic bladder-volume measurement in adults with BMI no greater than 30.

Modality
Ultrasound
Anatomy
Urinary bladder
Decision
2026-04-17